(Q70521383)

English

Long-term double-blind evaluation of amlodipine and nadolol in patients with stable exertional angina pectoris. The Investigators of Study 152

scientific article published on 01 January 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8416762%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

Long-term double-blind evaluation of amlodipine and nadolol in patients with stable exertional angina pectoris. The Investigators of Study 152 (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8416762%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

author name string

S Singh

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8416762%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

publication date

1 January 1993

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8416762%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

Clinical Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8416762%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8416762%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

54-58

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8416762%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8416762%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of amlodipine in renal impairment

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

Amlodipine pharmacokinetics in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined therapy with verapamil and propranolol in chronic stable angina

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical safety and efficacy of once-daily amlodipine for chronic stable angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of amlodipine in vasospastic angina: an interim report of a multicenter, placebo-controlled trial. The Investigators of Study 160

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiischemic properties of amlodipine, a new calcium antagonist, in patients with severe coronary artery disease: a prospective trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

Amlodipine: a once-daily calcium antagonist in the treatment of angina pectoris--a parallel dose-response, placebo-controlled study. The Amlodipine Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of carteolol and nadolol in the treatment of stable angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the duration of action of atenolol and nadolol for treatment of angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

Nadolol versus diltiazem and combination for preventing exercise-induced ischemia in severe angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of bepridil with nadolol for angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

Whole-body composition in patients with angina pectoris receiving long-term treatment with the nonselective beta-receptor blocking drug nadolol

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

Exercise stress testing in evaluation of patients with ischemic heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

A four-week double-blind, placebo-controlled, parallel dose-response study of amlodipine in patients with stable exertional angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy of amlodipine in myocardial ischemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

Amlodipine in angina pectoris: effect on maximal and submaximal exercise performance

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160112

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CLC.4960160112

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8416762%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8416762%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q70521383&oldid=1734056863"